Abstract
Background
Although controversial, it has been proposed that the use of leave-on facial skin care products, namely daily facial moisturizers with sun protection factor (SPF), is associated with frontal fibrosing alopecia (FFA). In accordance, several authors have previously reported on patch testing results in cross-sectional studies of patients with FFA.
Aims
The aim was to survey the top-selling facial moisturizers for the prevalence of potential allergens identified in FFA patient patch testing and to then distinguish if those moisturizers containing SPF were statistically more likely to have relevant potential allergens than moisturizers without SPF.
Methods
Three online retailers were surveyed for the best-selling facial moisturizers, and ingredient lists were reviewed for allergens found in FFA-patient patch testing and fragrance and botanical cross-reactors.
Results
Out of 100 unique facial moisturizers, 87 contained at least one potential allergen identified in previous patch testing results of FFA patients. There was no significant difference in the prevalence of indicated allergens in facial moisturizers with SPF in comparison to those without SPF.
Conclusion
It does not appear that the presence of additional identified allergens in facial moisturizers with SPF explains the reported association with FFA. Further prospective, comparative studies are necessary to understand the potential role of personal cosmetic products in the development of FFA.
References
MacDonald A, Clark C, Holmes S. Frontal fibrosing alopecia: a review of 60 cases. J Am Acad Dermatol. 2012;67(5):955–61.
Kossard S. Postmenopausal frontal fibrosing alopecia: scarring alopecia in a pattern distribution. Arch Dermatol. 1994;130(6):770–4.
Aldoori N, Dobson K, Holden CR, et al. Frontal fibrosing alopecia: possible association with leave-on facial skin care products and sunscreens; a questionnaire study. Br J Dermatol. 2016;175(4):762–7.
Cranwell WC, Sinclair R. Frontal fibrosing alopecia: regrowth following cessation of sunscreen on the forehead. Australas J Dermatol. 2019;60(1):60–1.
Cranwell WC, Sinclair R. Sunscreen and facial skincare products in frontal fibrosing alopecia: a case-control study. Br J Dermatol. 2019;180(4):943–4.
Debroy Kidambi A, Dobson K, Holmes S, et al. Frontal fibrosing alopecia in men: an association with facial moisturizers and sunscreens. Br J Dermatol. 2017;177(1):260–1.
Moreno-Arrones OM, Saceda-Corralo D, Rodrigues-Barata AR, et al. Risk factors associated with frontal fibrosing alopecia: a multicentre case-control study. Clin Exp Dermatol. 2018. https://doi.org/10.1111/ced.13785.
Donati A. Frontal fibrosing alopecia and sunscreens: cause or consequence? Br J Dermatol. 2016;175(4):675–6.
Ishizaki K, Yamada A, Yoh K, et al. Th1 and type 1 cytotoxic T cells dominate responses in T-bet overexpression transgenic mice that develop contact dermatitis. J Immunol Baltim Md. 2007;178(1):605–12.
Gay-Mimbrera J, Ruano J, Pavel AB, et al. 1322 Molecular profiling of frontal fibrosing alopecia (FFA) reveals TH1 and JAK-STAT up-regulation with no suppression of hair keratins [abstract]. J Invest Dermatol. 2018;138(5 Suppl):S225.
Rocha VB, Donati A, Contin LA, et al. Photopatch and patch testing in 63 frontal fibrosing alopecia patients: a case series. Br J Dermatol J. 2018;179(6):1402–3.
Aerts O, Bracke A, Goossens A, et al. Titanium dioxide nanoparticles and frontal fibrosing alopecia: cause or consequence? J Eur Acad Dermatol Venereol. 2019;33(1):e45–6.
DiNardo JC, Downs CA. Dermatological and environmental toxicological impact of the sunscreen ingredient oxybenzone/benzophenone-3. J Cosmet Dermatol. 2018;17(1):15–9.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
None.
Conflict of interest
D.H. Marks, A. Manatis-Lornell, D. Hagigeorges, J. Yu, and M.M. Senna have no conflicts of interest to report.
Rights and permissions
About this article
Cite this article
Marks, D.H., Manatis-Lornell, A., Hagigeorges, D. et al. No difference in relevant potential allergens in SPF-containing facial moisturizers: implications in frontal fibrosing alopecia. Drugs Ther Perspect 35, 347–349 (2019). https://doi.org/10.1007/s40267-019-00636-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40267-019-00636-6